NASDAQ:CPRX

Catalyst Pharmaceuticals Stock News

etoro logo Buy CPRX
*Your capital is at risk
$31.28
+0.0100 (+0.0320%)
At Close: Jun 03, 2026
U.S. stock futures traded lower this morning after recording losses in the previous session. Here are some big stocks recording losses in today’s pre-market trading session. FedEx Corporation (NYSE

Looking for a Growth Stock? 3 Reasons Why Catalyst (CPRX) is a Solid Choice

04:45pm, Thursday, 15'th Sep 2022 Zacks Investment Research
Catalyst (CPRX) could produce exceptional returns because of its solid growth attributes.
Catalyst (CPRX) could produce exceptional returns because of its solid growth attributes.

Catalyst (CPRX) Upgraded to Buy: Here's What You Should Know

04:00pm, Thursday, 15'th Sep 2022 Zacks Investment Research
Catalyst (CPRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Is Catalyst Pharmaceuticals (CPRX) Outperforming Other Medical Stocks This Year?

01:40pm, Thursday, 15'th Sep 2022 Zacks Investment Research
Here is how Catalyst Pharmaceutical (CPRX) and Lyell Immunopharma (LYEL) have performed compared to their sector so far this year.
Catalyst (CPRX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here is how Catalyst Pharmaceutical (CPRX) and Lyell Immunopharma (LYEL) have performed compared to their sector so far this year.

Catalyst Pharmaceuticals Ramp May Be Over For Now

03:33pm, Wednesday, 14'th Sep 2022
Catalyst Pharmaceuticals reached a 52-week high on September 13, 2022. Catalyst was recently added to the S&P SmallCap 600 Index.
U.S. stock futures traded higher this morning ahead of the PPI data for August. Here are some big stocks recording gains in today’s pre-market trading session. MAG Silver Corp. (NYSE: MAG) rose 8.5

As Markets Plunged, These 2 Stocks Hit All-Time Highs

09:53pm, Tuesday, 13'th Sep 2022 The Motley Fool
Some companies can stand up to tough conditions on Wall Street.
Some companies can stand up to tough conditions on Wall Street.
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis. Akero Therapeutics, Inc. (NASDAQ: AKRO) shares climbed 111
U.S. stocks traded lower, with the Dow Jones tumbling more than 800 points on Tuesday. Here are some big stocks recording gains in today’s session. NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) sur
Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an averag

Spectrum Pharmaceuticals (SPPI) Gets Nod for Rolvedon Injection

03:26pm, Monday, 12'th Sep 2022 Zacks Investment Research
Spectrum Pharmaceuticals (SPPI) receives FDA approval for its drug candidate, Rolvedon (eflapergrastim), for treating chemotherapy-induced neutropenia.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE